Grantham, Mayo, Van Otterloo & Co (GMO)’s KRONOS Worldwide KRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-24,500
Closed -$375K 793
2021
Q1
$375K Sell
24,500
-17,300
-41% -$259K ﹤0.01% 747
2020
Q4
$623K Sell
41,800
-10,600
-20% -$150K ﹤0.01% 648
2020
Q3
$674K Buy
52,400
+10,600
+25% +$127K ﹤0.01% 584
2020
Q2
$435K Buy
+41,800
New +$392K ﹤0.01% 645

Other funds holding KRO

Grantham, Mayo, Van Otterloo & Co (GMO)'s KRO Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of KRONOS Worldwide (KRO) in Q2 2021, closing a stake of 24,500 shares — an estimated $375K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in KRO in Q2 2020 and held it in 4 quarters. The position peaked at $674K in Q3 2020. 102 funds tracked by Wall St. Rank hold KRO as of Q2 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining KRONOS Worldwide position as of Q2 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 24,500 KRONOS Worldwide shares in Q2 2021, an estimated $375K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in KRONOS Worldwide in Q2 2020 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s KRONOS Worldwide position peaked at $674K in Q3 2020.
  • 102 funds tracked by Wall St. Rank held KRONOS Worldwide as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.